Australia - English - Department of Health (Therapeutic Goods Administration)

global medical solutions australia pty limited t/a radpharm scientific - medronic acid, quantity: 10 mg - injection, powder for - excipient ingredients: ascorbic acid; stannous chloride - indications as at 25 september 1996: technetium (99mtc) medronate may be used as a skeletal imaging pharmaceutical.

Australia - English - Department of Health (Therapeutic Goods Administration)

australian nuclear science and technology organisation t/a ansto - medronic acid, quantity: 5 mg - injection, powder for - excipient ingredients: ascorbic acid; stannous chloride dihydrate; hydrochloric acid; sodium hydroxide - a bone imaging agent to delineate areas of altered osteogenesis.

Ireland - English - HPRA (Health Products Regulatory Authority)

draximage (uk) limited - medronic acid - kit for radiopharmaceutical preparation - 10 milligrams per ampule

Israel - English - Ministry of Health

isorad ltd, israel - medronic acid - solution for injection - medronic acid 10 mg/vial - technetium (99mtc) medronic acid - technetium (99mtc) medronic acid - bone imaging.

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - epirubicin hydrochloride, quantity: 2 mg/ml - injection - excipient ingredients: sodium chloride; water for injections; hydrochloric acid - epirubicin hydrochloride is used in the treatment of: - breast, ovarian, stomach, lung and colorectal cancer - malignant lymphoma e.g. hodgkin's disease and non-hodgkin's lymphoma - multiple myeloma - non-invasive bladder cancer epirubicin is also used to help prevent recurrence of bladder cancer after surgery.

Ireland - English - HPRA (Health Products Regulatory Authority)

draximage (uk) limited - medronic acid - kit for radiopharmaceutical preparation - 10 milligrams per ampule

United States - English - NLM (National Library of Medicine)

jubilant draximage inc., dba jubilant radiopharma - medronic acid (unii: 73os0qin3o) (medronic acid - unii:73os0qin3o) - medronic acid 25 mg - the kit consists of reaction vials which contain the sterile, non-pyrogenic,non-radioactive ingredients necessary to produce technetium tc 99m medronate injection for diagnostic use by intravenous injection. mdp-25 reaction vials are intended to be used as multidose vials. each 10 ml mdp-25 reaction vial contains 25.0 mg medronic acid and not less than 2.0 mg of stannous chloride dihydrate (maximum total tin expressed as stannous chloride dihydrate 3.0 mg) and 5.0 mg of p-aminobenzoic acid in lyophilized form under an atmosphere of nitrogen. the ph is adjusted to 6.8 to 6.9 with hci or naoh prior to lyophilization. the addition of sterile, non-pyrogenic, and oxidant-free sodium pertechnetate tc-99m sterile solution produces a rapid labeling which is essentially quantitative and which remains stable in vitro throughout the 12-hours life of the preparation. no bacteriostatic preservative is present. the structural formula of medronic acid is: technetium tc-99m decays by isomeric transition with a ph

Australia - English - Department of Health (Therapeutic Goods Administration)

australian nuclear science and technology organisation t/a ansto - medronic acid -

Canada - English - Health Canada

jubilant draximage inc. dba jubilant radiopharma - medronic acid - powder for solution - 25mg - medronic acid 25mg - roentgenography

Canada - English - Health Canada

jubilant draximage inc. dba jubilant radiopharma - medronic acid - powder for solution - 10mg - medronic acid 10mg - roentgenography